Commonwealth Equity Services
AMAG

Commonwealth Equity Services’s AMAG Pharmaceuticals AMAG Stock Holding History

Commonwealth Equity Services’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-32,162
Closed -$753K – 2302
2016
Q1 		$753K Buy
32,162
+2,140
+7% +$50.8K 0.01% 1102
2015
Q4 		$906K Buy
+30,022
New +$970K 0.01% 976
2015
Q3 		– Sell
-11,807
Closed -$815K – 2260
2015
Q2 		$815K Buy
+11,807
New +$743K 0.01% 1071

Other funds holding AMAG

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
SIM
Stelliam Investment Management New York $404M AUM 5.1% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

Commonwealth Equity Services's AMAG Position: Q2 2016 in Review

Commonwealth Equity Services sold out of AMAG Pharmaceuticals (AMAG) in Q2 2016, closing a stake of 32,162 shares — an estimated $753K sold.

Commonwealth Equity Services first reported a position in AMAG in Q2 2015 and held it in 3 quarters. The position peaked at $906K in Q4 2015. 165 funds tracked by Wall St. Rank hold AMAG as of Q2 2016.

  • Commonwealth Equity Services reported no remaining AMAG Pharmaceuticals position as of Q2 2016 after selling out during the quarter.
  • Commonwealth Equity Services sold 32,162 AMAG Pharmaceuticals shares in Q2 2016, an estimated $753K.
  • Commonwealth Equity Services first reported a position in AMAG Pharmaceuticals in Q2 2015 and held it in 3 quarters.
  • Commonwealth Equity Services's AMAG Pharmaceuticals position peaked at $906K in Q4 2015.
  • 165 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q2 2016.

Based on Commonwealth Equity Services's 13F filing for Q2 2016, filed 4 Aug 2016.